Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hematologic Diseases × Vancomycin × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 3 Melanoma 2 Carcinoma, Hepatocellular 2 Stomach Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Liver Neoplasms 1 Febrile Neutropenia 1 Early Stage Non-Small Cell Lung Cancer 1 Breast Neoplasms 1

Interventions

pirtobrutinib 6 Mycophenolic Acid 5 Cyclophosphamide 5 fludarabine phosphate 4 Rituximab 4 Melphalan 4 Azacitidine 4 ibrutinib 3 fludarabine 3 Whole-Body Irradiation 3 Tacrolimus 3 Mesna 3 venetoclax 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Cyclosporine 2 Busulfan 2 Brentuximab Vedotin 2 Bone Marrow Transplantation 2 Blood Specimen Collection 2 Bendamustine Hydrochloride 2 zanubrutinib 1 spartalizumab 1 sabatolimab 1 ruxolitinib 1 ponatinib 1 pembrolizumab 1 nilotinib 1 idelalisib 1 cedazuridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡